Simcere Pharmaceutical Group (SCR) Posts Q4 Loss of 6c/ADS
Tweet Send to a Friend
Simcere Pharmaceutical Group (NYSE: SCR) reported Q4 loss of $0.06 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
